T. Rowe Price Investment Management Inc. cut its TechnipFMC plc stake by 20.1% in the fourth quarter, selling 5,830,783 shares and leaving it with 23,232,013 shares worth $1,035,219,000. The move trims a large position, but it does not remove the investment from the register.
The filing landed as investors were already parsing fresh ownership data in TechnipFMC, where hedge funds and other institutional investors still control 96.58% of the stock. That keeps T. Rowe Price inside a crowded institutional base even after the reduction, and it makes the size of the cut more notable than the fact that the firm stayed invested.
The quarter-end stake amounted to 5.74% of TechnipFMC, according to the filing, which ties the change to a recent Form 13F report filed with the Securities and Exchange Commission. In other words, the question is not whether T. Rowe Price exited. It is why one of the company’s biggest holders chose to lighten up by more than five million shares while still keeping more than $1 billion on the books.
That same backdrop included a separate transaction from Director Rousset Sophie Zurquiyah, who sold 6,350 shares on Tuesday, March 24th at an average price of $69.32 for a total of $440,182.00. After that sale, Zurquiyah still owned 59,887 shares valued at $4,151,366.84, a 9.59% decrease in ownership. The overlap matters because it shows selling at both the institutional and insider levels, even as the stock continued to draw favorable attention from Wall Street Zen, Weiss Ratings, Royal Bank Of Canada, UBS Group and Jefferies Financial Group.
What remains unanswered is the motive behind the quarter’s reduction. The filing fixes the math, but not the reason, and that leaves T. Rowe Price’s move as a deliberate shift in exposure rather than a full retreat from TechnipFMC.
